期刊文献+

盐酸莫西沙星片Beagle犬体内药代动力学 被引量:2

Pharmacokinetics of Moxifloxacin Hydrochloride Tablet After oral administration in Beagle dogs
暂未订购
导出
摘要 目的建立Beagle犬血浆样品中莫西沙星HPLC测定方法,研究Beagle犬口服盐酸莫西沙星片后体内药动学。方法色谱柱:依利特C18色谱柱(4.6mm×250mm,5μm);流动相:乙腈-0.05mol/L磷酸盐缓冲液(含0.01mol/L四丁基硫酸氢铵,pH=3.8)=15:85;检测波长:295nm;柱温:25℃;流速:1.0mL/min;进样量:20μL。Beagle犬口服盐酸莫西沙星片后定时取血,HPLC法测定血浆药物浓度,DAS2.0软件计算药动学参数。结果莫西沙星在Beagle犬体内的药-时曲线符合二室开放模型,主要药动学参数Tmax为(3.33±0.23)h,Cmax为(7.35±0.40)μg/mL,AUC为(118.37±13.05)μg/mL.h,t1/2α为(3.64±0.34)h,t1/2β为(13.49±0.50)h。结论此测定方法操作简单,专属性强,重现性好,所得药动学参数有助于对莫西沙星的进一步研究。 Objiective To establish a high performance liquid chromatographic (HPLC) method for the measurement of moxifloxacin in the plasma of Beagle dogs, and to investigate the pharmacokinetics of moxifloxacin hydrochloride tablet in Beagle dogs. Method The analysis was performed on a Elite C18 column (4.6mm~×250 mm, 5μm) at 25℃ with the mobile phase of acetonitrile-water (0.05mol/L buffer phosphate with 0.01mol/L tetrabutylammonium hydrogen sulfate, pH=3.8) 15:85 at a flow rate of 1.0mL/min, the sample size was 20μL and the detect wavelength was 295nm. The concentrations of moxifloxacin in the plasma of Beagle dogs were determined by HPLC method and the pharmacokinetic parameters of moxifloxacin were calculated by DAS2.0 soft ware. Results Mean plasma concentration-time curve of moxifloxacin in Beagle dogs was in line with two-compartments model. Main pharmacokinetic parameters were as follows: Tmax: (3.33±0.23) h, Cmax (7.35±0.40) μg/mL, AUC : (118.37±13.05) μg/mL h, t1/2α(3.64 ±0.34) h, tl/2β(13.49±0.50) h. Conclusion The methodis specificitive, reproducible and easy to process. The obtained pharmacokinetic parameters of moxifloxacin will be helpful for the further study of moxifloxacin.
出处 《国外医药(抗生素分册)》 CAS 2012年第2期87-90,共4页 World Notes on Antibiotics
基金 河北省卫生厅科学基金资助项目(编号:05093)
关键词 盐酸莫西沙星片 BEAGLE犬 高效液相色谱法 药动学 moxifloxacin hydrochloride tablet Beagle dogs HPLC pharmacokinetics
  • 相关文献

参考文献9

二级参考文献45

  • 1施毅,康晓明,储小曼,夏锡荣,卓海通,刘堃.环丙沙星和氧氟沙星对氨茶碱药代动力学的影响[J].中国临床药理学杂志,1994,10(4):206-210. 被引量:13
  • 2张吟,陈一农,陈文发.固相萃取-高效液相色谱法测定人血清中莫西沙星浓度[J].中国医院药学杂志,2007,27(4):481-483. 被引量:24
  • 3钟淑卿 莫红樱 张永昶 等.氟喹诺酮类对缓释茶碱茶喘平药动学的影响[J].中华结核和呼吸杂志,1995,18(4):240-240.
  • 4Stass H,Rink AD,Delesen H,et al.Pharmacokinetics and peritoneal penetration of moxifloxacin in peritonitis[J].J Antimicrob Chemother,2006,58 (3):693-696.
  • 5Vishwanathan K,Bartlett MG,Stewart JT.Determination of moxifloxacin in human plasma by liquid chromatography electrospray ionization tandem mass spectrometry[J].J Pharm Biomed Anal,2002,30(4):961-968.
  • 6Balfour JA,Wiseman LR.Moxifloxacin[J].Drugs,1999,57(3):363-373.
  • 7[18]Stass HH, Muller F, Hundt HK, et al. Study of the influence of once-daily 400 mg moxifloxacin on pharmacokinetics and pharmacodynamics of warfarin in healthy volunteers. [C]. 38(th) Intersci Conf Antimicrob Agents Chemother, Sept 24-2 7, San Diego, 1998, Abst A13
  • 8[19]Stass HH, Kubitza D, Schwietert H, et al. Bay12-8039 does not interact with t heophylline. [C]. 20(th) Int Cong Chemother, June 29-July 3, Sydney, 1997, Abst3 356
  • 9[20]Krasemann C, Meyer JM, Springsklee M. Moxifloxacin (MFX) in community-acquired pneumonia (CAP)-A bacteriologic and clinical meta-analysis. [J]. Clin Microbiol Infect, 1999,5(Suppl 3): Abst 205
  • 10[21]Petipretz P. Moxifloxacin(MFX) versus amoxycillin(AMOX) in the treatment of community -acqnired suspected pneumococcal pneumonia: A mutinational double -blind randonized study. [J]. Clin Microbiol Infect, 1999,5(Suppl 3):Abst 207

共引文献933

同被引文献16

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部